VITACCESS RUNNER-UP OF THE CIS TECHNOLOGY EXCELLENCE AWARD 2018 AT THE OXFORDSHIRE BUSINESS AWARDS
Being one of the two finalists in the CIS Technology Excellence Award, the team was thrilled to be selected alongside Sesui Ltd and congratulates them on their win. It has been a pleasure sharing this adventure with them.
For 24 years, the Oxfordshire Business Awards (OXBA) has been recognising, rewarding and promoting the excellence of Oxfordshire-based companies. Organised and supported by 14 of the county’s leading organisations, the awards are firmly established as a benchmark for excellence in today’s competitive business environment and were held at the John Henry Brookes Building at Oxford Brookes University.
Recognised experts in health economics, outcomes research and market access consulting to the pharmaceutical industry, the company has also launched “MyRealWorld™”, its unique and pioneering digital platform capturing data directly from patients (“real world evidence” research) on specially developed apps that run on their own mobile device. This research gives real-time insights into how diseases and treatments impact patients’ everyday lives.
Jon Spinage, director of technology at Vitaccess explains: “Our current IT infrastructure is hosted in the Cloud. The smart use of technology is an important part of our business, allowing us to reach out to patients in real-time. Vitaccess creates disruptive digital real-world evidence (RWE) apps, to improve care and patient outcomes via cost-effective technology and real-time access to patient-reported data. The benefits are: tailored data capture and evidence generation; "bring your own device" technology on any device, in any language, any country; real-time data access, and the highest level" of data security. MyRealWorld™ is a highly scalable platform for both iOS and Android. It allows us to create intuitive and personalised apps that help patients keep everything related to their condition at hand.”
Vitaccess has a unique business model which puts patients and charities at the heart of research, including partnering with patient charities to build “syndicated registries”.
We launched a syndicated digital melanoma registry in October 2017 in partnership with Melanoma UK with other registries in development later in 2018.
For further information please contact email@example.com.